| Clinical study "common" name (formal title) | Number of enrollees (per protocol [PP]/intent-to-treat [ITT]) | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year completed | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
|
VIP (Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia With Verteporfin: 1-Year Results of a Randomized Clinical Trial VIP Report No. 1) |
N=120 | 36617 | Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial VIP report no. 1. Ophthalmology. 2001;108(5):841-852. https://www.aaojournal.org/article/S0161-6420(01)00544-9/fulltext |
|